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Abstract
We reported previously that sheep affected with footrot (FR) have lower whole-blood selenium (WB-Se)
concentrations and that parenteral Se-supplementation in conjunction with routine control practices accelerates
recovery from FR. The purpose of this follow-up study was to investigate the mechanisms by which Se facilitates
recovery from FR. Sheep affected with FR (n = 38) were injected monthly for 15 months with either 5 mg Se (FR-
Se) or saline (FR-Sal), whereas 19 healthy sheep received no treatment. Adaptive immune function was evaluated
after 3 months of Se supplementation by immunizing all sheep with a novel protein, keyhole limpet hemocyanin
(KLH). The antibody titer and delayed-type hypersensitivity (DTH) skin test to KLH were used to assess humoral
immunity and cell-mediated immunity, respectively. Innate immunity was evaluated after 3 months of Se
supplementation by measuring intradermal responses to histamine 30 min after injection compared to KLH and
saline, and after 15 months of Se supplementation by isolating neutrophils and measuring their bacterial killing
ability and relative abundance of mRNA for genes associated with neutrophil migration. Compared to healthy
sheep, immune responses to a novel protein were suppressed in FR-affected sheep with smaller decreases in FR-
affected sheep that received Se or had WB-Se concentrations above 250 ng/mL at the time of the immune assays.
Neutrophil function was suppressed in FR-affected sheep, but was not changed by Se supplementation or WB-Se
status. Sheep FR is associated with depressed immune responses to a novel protein, which may be partly restored
by improving WB-Se status (> 250 ng/mL).
Introduction
Footrot (FR) is a common, contagious bacterial disease
of sheep that results in lameness and large production
losses for the sheep industry. Footrot is caused by infec-
tion with the bacterium Dichelobacter nodosus,ag r a m -
negative, anaerobic and fastidious bacterium, in associa-
tion with other bacteria, particularly Fusobacterium
necrophorum [1-3]. When the interdigital skin of the
foot is damaged or wet for a prolonged period of time,
it may become invaded by the ubiquitous soil and fecal
bacterium F. necrophorum. F. necrophorum causes inter-
digital dermatitis and produces toxins that cause necro-
sis of the superficial layer of the skin allowing co-
infection with other bacteria such as D. nodosus. D.
nodosus contains surface fimbriae and stable extracellu-
lar proteases that allow it to colonize the interdigital
epithelial tissue, digesting the living dermis, and feeding
on collagen [4,5]. A foul smell is associated with the
accumulation of grey pasty exudate between the dermis
and epidermal horn, and ultimately separation of the
hoof horn from the underlying dermis occurs [5].
Although a program that requires strict culling during
the hot, dry summer months (non-transmission period)
has proven successful in eliminating FR in flocks in
Western Australia [6], this protocol is unfeasible in
other countries with cool, wet climates and widespread
prevalence of infected flocks [5]. In these situations,
management programs to control rather than eliminate
infection are more important. Strategies include parent-
eral antibiotic treatment, topical antibacterial sprays,
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sity, and genetic selection for sheep breeds less suscepti-
ble to FR [5,7].
The role of the immune system in the etiology of FR
is not well understood. Adaptive immunity, including
humoral and cell mediated immunity (CMI), likely play
a role in protection against FR [8,9], yet infected or vac-
cinated sheep do not develop long-term immunity and
may become re-infected over time [5,10,11]. T-cell anti-
gen presentation may be biased between strains of D.
nodosus because vaccination with a polyvalent serotype
vaccine does not protect against all strains equally [8].
Heritability of resistance to FR may be related to a spe-
cific range of MHC II haplotype that is required to gen-
erate a sufficient immune response to D. nodosus [9].
We reported previously that FR-affected sheep have
lower whole-blood selenium (WB-Se) concentrations
and that parenteral Se-supplementation in conjunction
with routine control practices accelerates recovery from
FR [12]. As a follow-up, we examined in this study the
mechanisms by which Se may facilitate recovery from
FR. Selenium deficiency results in immunosuppression
and inhibits resistance to bacterial and viral infections,
neutrophil function, antibody production, proliferation
of T and B lymphocytes in response to mitogens, and
cytodestruction by T lymphocytes and NK cells [13]. It
is unknown whether Se supplementation to Se-replete
ewes can improve innate immunity of neutrophils (bac-
terial killing) or acquired immunity, including humoral
and CMI, in FR-affected sheep. We hypothesized that Se
functions as an immunonutrient, and enhances both
arms of the immune response and, thereby, accelerates
the recovery from FR. Because immune responsiveness
in sheep with FR, and the ability of Se to alter immune
responses to a foreign protein in sheep with FR are not
well understood, we used a broad approach. We mea-
sured the antibody titer and performed a delayed-type
hypersensitivity (DTH) skin test to a novel protein, key-
hole limpet hemocyanin (KLH), to assess humoral and
CMI, respectively, in healthy and FR-affected sheep.
Innate immunity was evaluated by measuring an intra-
dermal histamine response, and by isolating neutrophils
and assessing bacterial killing ability and relative abun-
dance of mRNA for genes associated with neutrophil
migration.
Materials and methods
Animals and study design
The animals and study design have been described in
detail previously [12], including the WB-Se assay and
foot scores. In short, this was a placebo-controlled clini-
cal trial of 15-months duration involving crossbred, pri-
marily black-faced mature ewes (age: 2-6 y; body
weight: 100-110 kg). A commercial sheep flock was
chosen for the project based on a high incidence of FR
and the owner’s willingness to participate in a long-
term clinical trial. At the beginning of the study, FR-
affected ewes (n = 38; the duration of FR in the sheep
was unknown) were alternately randomized into two
treatment groups and at 1-month intervals injected sub-
cutaneously with 5 mg of Se (FR-Se; sodium selenite
containing 45.6% Se; MU-Se,
® Schering-Plough Animal
Health Corp., Union, NJ) or with 1 mL of saline solu-
tion (FR-Sal) for the duration of the study. A control
group of healthy sheep without FR (n =1 9 )w a sa l s o
identified at the beginning of the study; they received
no injections. Ear tags and paint brands were used to
identify the ewes. Sheep feet were examined, trimmed,
and scored for FR at 0, 3, 6, 9, and 15 months using a
scale of 0 (no evidence of FR), 1 (interdigital dermatitis,
presence of heat, and characteristic FR odor), 2 (initial
underruning of the hoof wall between the toes), 3
(underrunning of the sole), and 4 (extensive underrun-
ning of the sole and lateral walls of the hoof). The score
o ft h ef o o tw i t ht h eh i g h e s tl e s i o ns c o r ew a su s e df o r
the statistical analysis. The experimental protocol was
reviewed and approved by the Oregon State University
Animal Care and Use Committee.
All sheep were fed primarily on pasture, except for a
s h o r tp e r i o da r o u n dl a m b i ng time in early winter when
they were brought into the barn and fed hay silage. Rou-
tine farm management practices were not altered. A
custom-made mineral supplement (Sonka Custom
Mineral Premix, Wilbur-Ellis Company, Clackamas, OR,
USA) that contained Se was provided free choice to all
ewes throughout the duration of the study. The mineral
supplement contained 5.0% calcium, 4.5% phosphorus,
40.0% salt (NaCl), 6.0% magnesium, 120 mg/kg cobalt, 4
000 mg/kg manganese, 250 mg/kg iodine, 200 mg/kg Se,
5 000 mg/kg zinc, 250 000 I.U./lb vitamin A, 40 000 I.
U./lb vitamin D, and 200 I.U./lb vitamin E. The mineral
supplement was intended to be diluted with salt to pro-
vide 90 mg/kg Se as per the FDA-regulations for free-
choice minerals. Average consumption of the mineral
mixture by the sheep in this trial was not determined.
All sheep had equal access to the mineral product.
However, as is typical of free-choice mineral products,
there is significant individual variation in intake. Based
on the mineral’s salt content, expected daily intake
would be between 5 and 10 g/head resulting in Se
intake of 1-2 mg/d, which is higher than the 0.7 mg/d
(0.7 mg/d is considered equivalent to 0.3 mg/kg supple-
mental Se in the total diet) allowed by the FDA. The FR
control program in this flock consisted of a walk-
through formalin foot bath (used monthly or less often).
A FR-vaccination program was not used. No antibiotics
for FR treatment were administered. This program con-
tinued for all sheep for the duration of the study.
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keyhole limpet hemocyanin (KLH)
Adaptive immune function was evaluated after 3 months
of Se supplementation by immunizing all sheep twice 2-
weeks apart with 0.5 mL of KLH (500 μg of KLH emul-
sified in 1.0 mg of T1501 adjuvant for a total volume of
0.5 mL; administered intramuscularly) as previously
described [14]. One day after the second immunization,
intradermal skin testing was performed. Swelling and
induration following an intradermal challenge were mea-
sured in the DTH test to assess CMI response by T
cells. Intradermal injections of KLH were administered
in 2 wool-free sites on the ventro-lateral abdomen, and
circled using a felt-tip marker, and on the ear tip (in
only 40 of the 57 ewes because we had insufficient
KLH). No chemical restraint was used. Separate intra-
dermal injections of histamine and saline were adminis-
tered on the ventro-lateral abdomen. Individual
disposable tuberculin syringes were filled with heat-
aggregated KLH; histamine base (0.1 g/L; Histatrol, Cen-
ter Laboratories, Port Washington, NY, USA), a positive
control; or saline (0.9%), a negative control. A 25-gauge
needle was used to inject 0.05 mL of each of these intra-
dermally. The 0.05-mL dose of heat-aggregated KLH
consisted of approximately 3 mg of KLH, and was pre-
pared as described previously [14]. Measurements of
wheal diameter and thickness (ear tip) were made at 0.5,
24, 48, 72, and 96 h after intradermal injections. The
test was administered by the same person to all sheep.
Reactions were recorded according to the diameter of
induration and erythema. A reaction larger than the
negative control was considered positive. If a positive
reaction to the saline control was observed, its diameter
was subtracted from the other reactions. After 24 h, no
reactions to the saline control were noted.
Innate immune function was evaluated 30 min after
injection by measuring skin responses on the ventro-lat-
eral abdomen to intradermal injections of histamine,
KLH, or saline. Histamine produced an induration typi-
cally larger than the saline control, after which the reac-
tion subsided. Thus, these co n t r o l ss e r v e da l s oa st e s t s
of acute inflammation, in that any reaction larger than
the saline reaction, which represented the volume of
substance injected, was due to an acute inflammatory
reaction.
KLH antibody titer
The KLH antibody titer was also used to assess adaptive
immune function. The humoral immune response was
evaluated after 3 months of Se supplementation by mea-
suring the KLH antibody titer prior to the first 0.5 mL
KLH immunization and 2 and 4 weeks after the second
KLH immunization. Serum was assayed for KLH anti-
body titer by an indirect ELISA. Briefly, 96-well
microtiter plates (Costar, Cambridge, MA, USA) were
coated with 5 μg/mL of KLH (100 μL/well; Sigma Che-
mical Co., St. Louis, MO, USA) in a 0.1 M sodium
bicarbonate buffer, sealed to prevent evaporation, and
incubated at 4°C overnight. The next day the coating
solution was removed and 100 μL of StabilCoat (SurMo-
dics Inc., Eden Praire, MN, USA) was added to each
well to block nonspecific binding sites and plates were
incubated for 30 min at room temperature. After incu-
bation, the StabilCoat was removed; plates were re-
sealed and stored at 4 °C until used. Serum samples
were serially diluted (1:100 to 1:1,024,000) in 0.05 M
PBS with 0.05% Tween-20 (T-PBS; pH 8.0). Each dilu-
tion was added to the plate in duplicate, and incubated
for 30 min at room temperature. Positive and negative
control serums were included on each plate. After incu-
bation, plates were washed eight times with T-PBS and
then 100 μL of horseradish peroxidase conjugated to
rec-Protein G (Zymed Laboratories Inc., San Francisco,
CA, USA) was added to each well at a previously deter-
mined dilution (1:20,000). Rec-Protein G binds to IgG
immunoglobulin through their Fc regions and was used
instead of an anti-species conjugate as it resulted in
equivalent results with a stronger signal and less back-
ground. After another 30 min incubation at room tem-
perature, plates were again washed with T-PBS and 100
μLo f1 . 6μMA B T S / H 2O2 (2,2’-Azino-bis [3-ethyl-
benzthiazoline-6-sulfonic acid]; Sigma) in 0.1 M citrate
buffer (pH 4.0) was added to all wells. Plates were incu-
bated at room temperature in the dark and were read
when a positive reference sample reached an OD of 1.0.
The OD of each well at 405 nm was determined using a
Bio-Tek EL312 microplate reader (Bio-Tek Instruments
Inc., Winooski, VT, USA). The antibody titer was
expressed as an endpoint titer for each sample, which
was calculated from a regression line of OD against
sample dilution, with a threshold of 0.200 OD (approxi-
mately 3 times the OD generated by the background),
using a software program (KinetiCalc, Bio-Tek Instru-
ments Inc., Winooski, VT, USA).
Neutrophil bacterial killing of Lactococcus lactis
Bacterial killing by neutrophils was assessed after 15
months of Se supplementation. Neutrophils were iso-
lated using a Percoll gradient technique [15], resus-
pended in Hank’s balanced saline solution (HBSS) plus
0.5% FBS, and counted using a Coulter counter. Briefly,
10 mL of heparinized blood was collected via jugular
puncture, transported on ice to the lab, transferred into
50 mL tubes, and centrifuged at 1000 × g for 20 min at
4 °C in a swinging bucket centrifuge to separate plasma
and buffy coats from the red cell pack. Plasma, buffy
coat and one-third of the red cell pack from each tube
were aspirated aseptically and discarded. The remaining
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34 mL of ice-cold PBS. Samples were layered onto 10
mL of 1.084 g/mL Percoll (Sigma Chemical Company,
St. Louis, MO, USA), then centrifuged at 400 × g for 40
min at 22 °C. After centrifugation, the red blood cells
(RBC) and neutrophils pelleted at the bottom of the
tube and the mononuclear cell band remained at the
sample/medium interface. Supernatant, mononuclear
cell layer and Percoll were aspirated and discarded. Red
blood cells were lysed using 24 mL ice-cold hypotonic
lysing solution (10.56 mM Na2HPO4,2 . 6 7m M
NaH2PO4, pH 7.3) for 90 s. Isotonicity was restored by
adding 12 mL ice-cold hypertonic restoring solution
(10.56 mM Na2HPO4,2 . 6 7m MN a H 2PO4,0 . 4 3M
NaCl, pH 7.3). Remaining leukocytes were pelleted by
centrifugation at 800 × g for 5 min at 4 °C. A 20 μLa l i -
quot of the cell suspension was used to determine cell
concentration (Coulter ZB1 Counter, Coulter Electro-
nics Inc., Hialeah, FL, USA). Another 5 μLa l i q u o tw a s
used to assess purity of neutrophil preparations (differ-
ential cell count) by microscopic examination after
Wright-Giemsa staining (95 ± 1%; mean ± SEM).
Neutrophils (2 × 10
5 cells/well) were seeded into tri-
plicate wells of a 96-well tissue culture plate, previously
coated with poly-D-lysine. Neutrophils were activated
for 10 min with 25 nM PMA (diluted in DMSO; < 1%
final solution). Logarithmic phase Lactococcus lactis
(MG1363) bacteria containing an erythromycin-resistant
plasmid were grown in M17 + glucose (M17G) + ery-
thromycin media and diluted to the desired concentra-
tion in RPMI media + 2% heat-inactivated sheep serum
(Biomeda, Burlingame, CA, USA). Bacteria were added
to the neutrophils at a multiplicity of infection (MOI) of
0.01. After 1 h incubation at 37 °C in 5% CO2,m e d i ai n
the wells containing neutrophils and bacteria was seri-
ally diluted and plated onto M17G medium containing
erythromycin for overnight incubation and enumeration
of colony forming units (CFU). Internal control wells
without neutrophils were used to determine baseline
bacterial counts at the assay endpoints. Percent survival
of bacteria was calculated as [(CFU/mL experimental
well)/(CFU/mL control well)] × 100%.
Relative abundance of selected mRNAs specific for
neutrophil migration (L-selectin, IL-8R)
Gene expression by neutrophils was evaluated after 15
months of Se supplementation. Neutrophils were iso-
lated as described above and frozen at -80 °C. Total
RNA was extracted following manufacturer’si n s t r u c -
tions using a RNeasy
® Mini Kit (Qiagen Sciences; Ger-
mantown, MD, USA), quantified using the ND-1000
NanoDrop Spectrophotometer (Thermo Fisher Scienti-
fic; Waltham, MA, USA), and stored at -80 °C. Aliquots
of 500 ng RNA in 10 μL were used for RT-qPCR.
Relative mRNA abundance were determined for L-selec-
tin and IL-8R to evaluate gene expression of markers
involved in neutrophil migration, adherence, and activa-
tion using the Taqman
® One-Step RT-PCR Master kit
(Applied Biosystems, Branchburg, NJ, USA). Levels of
ribosomal protein large subunit family member (RPL-
19) mRNA were measured to normalize selected
mRNA. Results were expressed as fold change using the
relative quantification method of Pfaffl [16]. The abun-
dance of target genes, normalized to RPL-19 (as the
internal control) and relative to the control group of
sheep, were illustrated by 2
-ΔΔCt, where Ct was the cycle
number at which the fluorescence signal of the product
crossed an arbitrary threshold set with exponential
phase of the PCR and ΔΔCt = (Cttarget gene unknown sample
-C t RPL-19 unknown sample)-( C t target gene calibrator sample -
CtRPL-19 calibrator sample).
The RT-qPCR oligonucleotide primers for these genes
of interest are proprietary (OmniGen Research LLC,
Canby, OR, USA) and were designed based on bovine
DNA sequence data. To verify that these primers were
amplifying sheep cDNA, RT-qPCR primers were used to
amplify sheep genomic DNA. The products were run on
a 2% agarose gel and the approximately 125 base-pair
band was excised. The DNA fragment size was con-
firmed using a 50 base pair ladder, and selected bands
were excised and purified from the agarose gel using a
QIAquick Gel Extraction Kit (QIAGEN Inc., German-
town, MD, USA) according to manufacturer’si n s t r u c -
tions, and prepared for sequencing. Purified products
were sequenced at the Oregon State University Center
for Genome Research and Biocomputing (CORE Lab)
using a DNA sequencer machine. Sequence analysis was
performed using commercial software. The sequence
obtained was used in a BLAST (National Center for Bio-
technology Information, U.S. National Library of Medi-
cine, Bethesda, MD, USA) search of all known
mammalian genomic sequences. The search showed
96% sequence identity to bovine IL-8R alpha and 99%
sequence identity to bovine SELL (aliases: CD62 anti-
gen-like family member L; L-selectin; LAM-1; LECAM1;
leukocyte adhesion molecule 1; leukocyte-endothelial
cell adhesion molecule 1; lymph node homing receptor;
lymphocyte adhesion molecule 1; selectin L), the most
closely related species.
Statistical analysis
Statistical analyses were performed using SAS, version
9.2 (SAS, Inc., Cary, NC, USA) software. Antibody titers
for KLH were normalized by log2 transformation and
are shown as such. Relative mRNA abundance were
analyzed using the internal standard-adjusted Ct-values
(Cttarget gene unknown sample -C t RPL-19 unknown sample). Indi-
cators of innate and adaptive immunity were analyzed
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sis in time (PROC MIXED), respectively. Selenium treat-
ment (healthy, FR-Se, FR-Sal) or Se-status at the time of
the immune assays (healthy, FR-high Se, FR-low Se)
were the covariates. Ages and production stage of ewes
were not available for individual ewes in the commercial
flock and thus, were not included in the model. Ewes
were stratified by Se status because WB-Se concentra-
tions of FR-Se and FR-Sal sheep overlapped (Table 1)
[12]. The cut-off point for high and low Se was 250 ng/
mL Se in WB and was based on the median WB-Se
concentration of FR-affected sheep at the time of the
immune assays (3 and 15 months; [12]). For immune
assays with multiple samples in time, time of sample
collection and the interaction between time of sample
collection and Se treatment or status were added as
fixed effects. A completely unrestricted variance-covar-
iance structure was used to account for repeated mea-
sures taken from individual ewes across time. To obtain
the correct degrees of freedom, the KENWARDROGER
option was invoked. The KENWARDROGER option
consists of the Satterthwaite adjustment for degrees of
freedom with a Kenward-Roger adjustment on standard
errors, which can be used for repeated measures studies.
The effect of FR on indicators of immune function
was evaluated by comparing the estimated values of
the healthy group with those of the FR-affected groups.
The effect of Se supplementation on indicators of
immune function in FR-affected sheep was evaluated
by comparing the estimated values of the FR-Se with
those of the FR-Sal group. The effect of Se status on
indicators of immune function in FR-affected sheep
was evaluated by comparing the estimated values of
the FR-high Se with those of the FR-low Se group.
Data are reported as least square means ± SEM. Statis-
tical significance was declared at P ≤ 0.05 and tenden-
cies at 0.05 <P ≤ 0.15.
Results
Foot Lesions
Treatment with monthly Se injections accelerated recovery
from FR as previously reported [12]. Footrot-affected ewes
receiving Se had lower foot scores than FR-affected ewes
receiving saline (overall P = 0.04), with the primary differ-
ences being observed at 3 (P =0 . 0 7 )a n d6( P = 0.03)
months after starting Se supplementation (Figure 1a).
To assess the effect of WB-Se status on subsequent
foot scores, FR-affected ewes were stratified by WB-Se
concentration (cutoff value: 250 ng/mL) at 3 months,
prior to receiving the fourth monthly Se injection. Foo-
trot-affected ewes with WB-Se concentrations of at least
250 ng/mL (FR-High Se) had lower foot scores (overall
P = 0.02) than FR-affected sheep with WB-Se concentra-
tions below 250 ng/mL (FR-Low Se; Figure 1b). Greater
WB-Se concentrations after 3 months of Se treatment
predicted future recovery from FR. Foot scores were
decreased at 15 months compared to 3 months after
starting the study in FR-High Se ewes (P =0 . 0 4 )a n d
were similar to control sheep, whereas foot scores did
not change (P = 0.68) and remained high in FR-Low Se
ewes (Figure 1b). As a result, the primary differences for
ewes stratified by WB-Se status were observed 9 (P =
0.08) and 15 (P = 0.05) months after starting Se
treatment.
Cell-mediated immunity as measured by the delayed-type
hypersensitivity skin test with KLH
Sheep affected with FR had less of a DTH response than
healthy sheep, as measured by ear thickness (overall P =
0.006; Figure 2a), ear wheal diameter (overall P = 0.02;
Figure 2b), and body wheal diameter (overall P = 0.04;
Figure 2c). The location of the test site was important
for assessing the duration of the DTH response; the
DTH response decreased quickest for ear wheal dia-
meter (Figure 2b). Monthly Se injections improved part
of the DTH response in FR-affected sheep. Whereas ear
thickness decreased from 24 to 96 h in healthy sheep
and FR-Sal sheep, no significant change in ear thickness
was observed in FR-Se treated sheep (Figure 2a). As a
result, FR-Se sheep had a greater ear thickness than FR-
Sal sheep at 96 h after KLH challenge (P = 0.04) and a
similar ear thickness compared with healthy sheep (Fig-
ure 2a).
Footrot-affected sheep with higher WB-Se concentra-
tions (≥ 250 ng/mL) had more intense DTH responses
than FR-affected sheep with lower WB-Se concentra-
tions (< 250 ng/mL) as measured by ear thickness (P =
0.04; Figure 2d). Ear wheal diameter tended to be
greater in FR-High Se sheep compared to FR-Low Se
sheep after 72 h (P = 0.10) and 96 h (P = 0.13; Figure
2e), whereas Se status only numerically improved the
DTH response for body wheal diameter (Figure 2f).
Table 1 Whole-blood selenium concentrations in healthy
and footrot (FR) affected sheep treated with selenium
(FR-Se) or saline (FR-Sal)*
Median whole-blood Se (range); ng/mL
Month of
Treatment
Healthy FR-Se FR-Sal
0 250 (187 351)
a 199 (109 278)
b 202 (111 323)
b
3 245 (145 340)
a 261 (189 317)
a 199 (110 295)
b
6 274 (180 396)
b 302 (267 403)
a 268 (176 408)
b
15 230 (165 302) 288 (157 416) 237 (104 344)
*Adapted from Hall et al. [12]. Footrot-affected sheep (n = 38) were alternately
randomized into two treatment groups and at 1-month intervals injected
subcutaneously with 5 mg of Se (FR-Se) or with 1-mL of saline solution (FR-
Sal) for 15 months. A control group of 19 healthy sheep without FR received
no injections. There were 19 sheep/group at 0 and 3 months, 18 to 19 sheep/
group at 6 months, and 9 to 14 sheep/group at 15 months.
a, bMedians with different superscripts within month are different (P < 0.05).
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titer
Sheep affected with FR had lower KLH antibody titers 2
and 4 weeks after KLH immunization compared with
healthy sheep (overall P = 0.02), which was not altered
by Se treatment (Figure 3a). Selenium status tended to
be associated with a greater KLH antibody titer (Figure
3b). After stratification by Se status, FR-Low Se sheep
had lower KLH antibody titers compared with healthy
control sheep (P = 0.02), whereas FR-High Se sheep had
intermediary values (P = 0.09 versus healthy sheep and
P = 0.48 versus FR-Low Se sheep; Figure 3b).
Innate immunity measurements
Sheep affected with FR, regardless of Se treatment had
smaller ear wheal diameters compared with healthy
sheep 30 min after KLH challenge (P = 0.05; Figure 4a).
Monthly Se injections decreased the 30 min response to
histamine (P = 0.02; Figure 4a). Sheep with FR-High Se
status at the time of the DTH assay had a decreased
response to histamine at 30 min compared with FR-Low
Se sheep (P = 0.02; Figure 4b).
Sheep affected with FR had a lower percent neutrophil
bacterial killing of Lactococcus lactis compared with
healthy sheep (P = 0.04), which was not altered by Se
treatment (P = 0.36; Figure 4c). Whole blood-Se status
was not associated with altered neutrophil bacterial kill-
ing ability (P = 0.26; Figure 4d).
Sheep affected with FR had lower mRNA concentrations
of IL-8R compared with healthy sheep (P = 0.02), which
were not altered by Se treatment (P = 0.24; Figure 4e).
Relative abundance of L-selectin mRNA concentrations
were not affected by FR-status (P = 0.88) or Se treatment
(P = 0.56; Figure 4e). Whole blood-Se status in sheep with
FR was not associated with altered mRNA concentrations
of IL-8R (P = 0.32), but tended to be associated with
increased mRNA concentrations of L-selectin in FR-High
Se sheep (P = 0.07; Figure 4f).
Discussion
We reported previously that sheep affected with FR have
lower WB-Se concentrations and that parenteral Se-sup-
plementation in conjunction with routine control prac-
tices accelerates recovery from FR [12]. To determine
whether Se acts as an immunonutrient and improves
immune function in FR-affected sheep, we examined the
effect of FR, Se treatment, and WB-Se status on mea-
sures of CMI, humoral immunity, and innate immunity.
Our primary finding is that immune responses to a
novel protein (KLH) are attenuated in FR-affected sheep
with lower WB-Se status. Furthermore, the DTH and
antibody titer responses to a novel protein were
improved, in part, by Se treatment and high WB-Se sta-
tus, supporting our hypothesis that Se acts as an immu-
nonutrient in FR-affected sheep. Neutrophil function
w a ss u p p r e s s e db yF R ,b u tw a sn o tc h a n g e db yS es u p -
plementation or WB-Se status.
The purpose of this follow-up study was to investigate
the mechanisms by which Se facilitates recovery from
FR. The immune system has two functional divisions:
innate and adaptive immunity. Both divisions involve
various blood-borne factors (e.g., complement, antibo-
dies, and cytokines) and cells (e.g., neutrophils, lympho-
cytes, and macrophages). There is large individual
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Figure 1 Foot lesion scores in healthy and footrot-affected sheep treated with selenium or saline. Footrot-affected (FR) sheep receiving
monthly Se injections, had A) lower foot lesion scores (overall: P = 0.04), and in particular at 3 (P = 0.07) and 6 (P = 0.03) months after the start
of the study. B) After stratifying FR-affected sheep by whole-blood Se (WB-Se) status at 3 months after the start of the study (WB-Se cut-off: 250
ng/mL), sheep with WB-Se concentrations above 250 ng/mL (FR-High Se) had decreased foot lesion scores by the end of the study (P = 0.04),
whereas foot lesion scores did not change (P = 0.68) in sheep with WB-Se concentrations below 250 ng/mL (FR-Low Se). As a result, foot lesion
scores were lower in FR-High Se sheep compared with FR-Low Se sheep (overall P = 0.02).
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Page 6 of 11variation in immune function even among healthy ani-
mals. For example, differences in genetics, age, gender,
levels of exercise, diet, stress, infectious disease history,
vaccination status, and early life experiences are impor-
tant contributors to this observed variation [17]. Thus,
demonstrating an improvement in immune function
with Se supplementation is challenging.
Tests used to assess adaptive immunity include the DTH
test, which is also known as a type IV hypersensitivity
reaction. This test provides a general measure of CMI.
Professional antigen presenting cells, e.g., dendritic cells,
present antigen to T lymphocytes. This results in antigen-
specific activation of T lymphocytes in local tissues.
Inflammatory cytokines produced by these stimulated T
lymphocytes cause other mononuclear cells (lymphocytes
and macrophages) to migrate to the area and proliferate.
To perform this test, foreign antigen is injected under the
epidermis of the skin. The immune system responds to
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Figure 2 Delayed-type hypersensitivity skin test responses in healthy and footrot-affected sheep treated with selenium or saline.
Footrot-affected (FR) sheep had an attenuated delayed-type hypersensitivity (DTH) response to keyhole limpet hemocyanin (KLH) compared with
healthy sheep, as measured by A) ear thickness (overall: P = 0.006), B) ear wheal diameter (overall: P = 0.02), and C) body wheel diameter
(overall: P = 0.04). Treatment of FR affected sheep with selenium (FR-Se) for 3 months improved the DTH response in FR-Se affected sheep, as
measured by A) ear thickness (96 h after KLH challenge: P = 0.04 compared to FR-Saline sheep), and B) ear wheal diameter (72 h after KLH
challenge: P = 0.09). After stratifying FR-affected sheep by whole-blood Se (WB-Se) status at the time of the immune assay (WB-Se cut-off: 250
ng/mL), sheep with WB-Se concentrations above 250 ng/mL (FR-High Se) had stronger DTH responses to KLH than sheep with WB-Se
concentrations below 250 ng/mL (FR-Low Se), as measured by D) ear thickness (overall: P = 0.04), E) ear wheal diameter (72 h after KLH
challenge: P = 0.10), but not by F) body wheel diameter (overall: P = 0.58).
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Page 7 of 11this antigen by producing a small raised wheal that can be
measured 24 to 96 h after injection. The larger the wheal,
the greater is the CMI response.
In our study, healthy control sheep demonstrated an
enhanced CMI response to a novel protein (KLH) com-
pared with FR-affected sheep based on the DTH test.
Results were more definitive for the ear tip compared
with two wool-free sites on the ventro-lateral abdomen,
likely because higher tissue compliance allowed a more
diffuse DTH reaction on the abdomen. For this reason,
the latter may not be as useful of a test location as the
ear tip for this assay in sheep. Both ear thickness and
ear wheal diameter were similarly affected, although the
DTH response resolved faster over time for ear wheal
diameter. The DTH response in healthy sheep receded
from 24 to 96 h. Although ear thickness was suppressed
at 24 h in FR ewes compared to healthy controls, there
was no change across time in FR-Se treated sheep.
Thus, by 96 h FR-Se sheep had a greater ear thickness
than FR-Sal sheep and a similar ear thickness compared
with healthy control sheep. Similarly, FR-affected sheep
with higher WB-Se concentrations had a more intense
DTH response than FR-affected sheep with lower WB-
Se concentrations. Our results suggest an attenuated T-
lymphocyte response in FR-affected sheep, which could
be the result of decreased activation, migration, prolif-
eration, or a combination of these, and which may be
improved, in part, by Se treatment. An enhanced DTH
response after Se supplementation was also shown by
Lacetera et al. [18]. In their study, ewes given a single 5
mg Se injection 30 d prior to lambing had a greater
DTH response to intradermal phytohaemagglutinin
(PHA) injection at 6 h than ewes not treated with Se.
Lambs born to Se-treated ewes had a greater DTH
response to PHA 24 h after injection. In this study as
well as ours, Se was supplemented to Se-adequate
sheep. Methodology differences with injection site (ear
vs. neck), antigen (KLH vs. PHA), response time (days
vs. hours), and measurement technique (wheal reaction
vs. skin thickness) likely account for differences between
the studies.
Measuring an antibody titer in response to sensitiza-
tion/immunization is another test to assess the adaptive
(humoral) immune response. The animal is injected
with a novel protein (e.g., KLH) that elicits an immune
response. Following sensitization, antibody titers to KLH
can be measured. Our results showed that FR disease
was associated with lower KLH antibody titers 2 and 4
weeks after KLH immunization compared with healthy
sheep, suggesting a lower antibody titer to a novel pro-
tein in FR-affected sheep. Stratification by WB-Se status
showed that sheep with FR-High Se had KLH antibody
titers more similar to healthy control sheep 14 days
after the second immunization. There was no difference
in antibody titers between FR-Se and FR-Sal treated
ewes at 28 days, suggesting that titers may rise more
rapidly in FR-Se treated ewes, similar to what we have
s h o w ni nc a t t l e[ 1 9 ] .O u rr e s u l t ss u g g e s tt h a tS em a y
improve antibody producti o ni nr e s p o n s et oan o v e l
protein in FR-affected sheep. It would be interesting to
look at earlier titers in future studies, for example at 7
days after the second immunization.
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Figure 3 Antibody titers to keyhole limpet hemocyanin in healthy and footrot-affected sheep treated with selenium or saline. Footrot-
affected (FR) sheep, regardless of Se treatment, had A) lower keyhole limpet hemocyanin (KLH) antibody titers 2 and 4 weeks after the second
KLH immunization compared with healthy sheep (overall: P = 0.02). B) After stratifying FR-affected sheep by whole-blood Se (WB-Se) status at
the time of the immune assay (WB-Se cut-off: 250 ng/mL), sheep with WB-Se concentrations below 250 ng/mL (FR-Low Se) had lower KLH
antibody titers compared with healthy sheep (overall: P = 0.02), whereas sheep with Se concentrations above 250 ng/mL (FR-High Se) had
intermediate values (overall: P = 0.09 versus healthy sheep; overall: P = 0.48 versus FR-Low Se sheep).
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Page 8 of 11Sheep affected with FR, regardless of Se treatment had
smaller ear wheal diameters compared with healthy sheep
30 min after KLH challenge. This is consistent with a
reduction in the type I hypersensitivity reaction normally
induced by histamine and inflammatory cytokines. The
KLH stimulates inflammatory cytokine production. Bac-
terial infection may cause immunosuppression of Type I
hypersensitivity by affecting the release of histamine, or
virulence factors such as leukotoxin, endotoxin, haemoly-
sin, haemagglutinin and adhesin that are used to overcome
the host’s defense mechanisms when infection is estab-
lished may also suppresses the immune response.
Selenium treatment decreased the 30 min skin-test
response to histamine in FR-affected sheep. Histamine
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Figure 4 Innate immunity measurements in healthy and footrot-affected sheep treated with selenium or saline. Footrot-affected (FR)
sheep, regardless of Se treatment, had A) smaller ear wheal diameters compared with healthy sheep 30 min after KLH challenge (P = 0.05),
whereas Se treatment decreased the 30 min response to histamine (P = 0.02). B) After stratifying FR-affected sheep by whole-blood Se (WB-Se)
status at the time of the DTH assay (WB-Se cut-off: 250 ng/mL), sheep with WB-Se concentrations above 250 ng/mL (FR-High Se) had a
decreased response to histamine at 30 min (P = 0.02). C) FR-affected sheep had a lower percent neutrophil bacterial killing of Lactococcus lactis
compared with healthy sheep (P = 0.04), which was not altered by Se treatment (P = 0.36), or D) Se status (P = 0.26). E) FR-affected sheep had
lower mRNA concentrations of IL-8R compared with healthy sheep (P = 0.02), which were not altered by Se treatment (P = 0.24), or F) Se status
(P = 0.32). FR-High Se status sheep tended to have increased mRNA concentrations of L-selectin (P = 0.07).
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Page 9 of 11normally increases capillary permeability and relaxes
vascular smooth muscle, allowing edema fluid accumu-
lation. Influx of proinflammatory cytokines triggers pro-
duction of reactive oxygen species (ROS). When
produced in excess, ROS are important mediators of cell
and tissue injury. Because Se is involved in redox reac-
tions, and immune activation is usually associated with
increased production of ROS by cells of the immune
system, higher Se may help suppress tissue damage
caused by ROS (reviewed in Murr et al. [20]). As a com-
ponent of the glutathione peroxidase family of enzymes,
Se contributes to the reduction of hydroperoxides in
cells. Glutathione peroxidase reduces ROS to less reac-
tive metabolites, decreasing oxidant stress. We suggest
that Se suppressed oxidative stress and attenuated the
early skin-test reaction at 30 min. Thus, Se may protect
from type I hypersensitivity reactions, involving IgE anti-
body triggering of mast cells and oxidative insult, by
preventing lipid hydroperoxide accumulation. On the
other hand, Se enhanced the type IV hypersensitivity
reaction at 96 h.
Neutrophils are the most numerous and important
cellular component of innate immunity. Their primary
functions are phagocytosis and destruction of microor-
ganisms. They serve as the body’s first line of defense
against invading microorganisms. Phagocytosed bacteria
are rapidly killed by proteolytic enzymes (e.g., myeloper-
oxidase), antimicrobial proteins, and ROS when mem-
brane-bound granules fuse with phagocytic vesicles. In
addition to phagocytosis, bacterial killing occurs via neu-
trophil extracellular traps (NETs) [21-23]. Upon activa-
tion, neutrophils release extracellular fibers called NETS,
which form a meshwork that kills bacteria extracellularly
without the need for phagocytosis. NETs are made up of
DNA, histones, and granule proteins such as elastase.
Both Gram-positive and Gram-negative bacteria are
killed, which suggests that NETs can kill a wide range
of pathogens. These NETs serve as a physical barrier,
which prevents the spread of bacteria.
To assess innate immunity of neutrophils, a biologic
assay was performed using Lactococcus lactis and mea-
suring percent bacterial killing. Neutrophils from
healthy control sheep demonstrated higher percent bac-
terial killing compared with neutrophils from FR-
affected sheep, regardless of 15 months of Se supple-
mentation. Even when FR-affected sheep were stratified
by WB-Se status, neutrophil bacterial killing ability was
not altered. Our results suggest that FR-affected sheep
have reduced neutrophil bacterial killing ability, which
c a n n o tb ei m p r o v e db yS es u p p l e m e n t a t i o no rh i g h
WB-Se status. It has been reported previously that neu-
trophils of Se-deficient cattle have reduced ability to kill
phagocytosed bacteria [24,25]. Although acute infections
have been shown to decrease serum-Se levels [26],
sheep in the current study were Se-adequate. It is possi-
ble that supranutritional Se does not further improve
neutrophil bacterial killing ability or that the disease
state inhibits or prevents modulation of neutrophil bac-
terial killing ability.
Measuring the relative abundance of mRNA specific
for neutrophil migration activity (L-selectin and IL-8R)
by RT-qPCR is another method for assessing innate
immunity. To protect against invading pathogens, neu-
trophils migrate to infected sites. Neutrophils roll along
walls of blood vessels by the coordinated formation and
breakage of selectin-carbohydrate chemical bonds. L-
selectin is a cell surface glycoprotein that is constitu-
tively expressed on the surface of most leucocytes [27].
L-selectin is important for the binding and subsequent
rolling of leucocytes along endothelial walls, facilitating
migration into secondary lymphoid organs (e.g., naive T
cells) and into sites of inflammation (e.g., neutrophils)
[27]. Chemokines such as IL-8 and its receptor control
the interaction of neutrophils with the epithelial cell
barrier. IL-8 is recognized mainly for its ability to induce
neutrophil migration, but it also increases cytokine pro-
duction, enhances phagocytosis and ROS generation,
and regulates cell survival [28-30]. In our study, we
found that sheep affected with FR had lower concentra-
tions of IL-8R mRNA compared with healthy sheep, and
Se treatment had no effect. Our results suggest that
attenuated IL-8R gene expression may play a role in
reducing bacterial killing ability in FR-affected sheep;
IL-8R gene expression, however, may not be responsive
to Se treatment. The relative abundance of L-selectin
mRNA was not affected by FR-status, however, mRNA
concentrations tended to be higher in FR-High Se
sheep, suggesting that L-selectin is a potential molecular
target of Se treatment.
In conclusion, our goal was to determine if supple-
menting Se at concentrations above those currently
recommended for sheep (supranutritional) can modulate
the immune response in a way that reduces severity and/
or improves recovery from a disease process. We
reported previously that parenteral Se supplementation
in conjunction with routine control practices resulted in
higher WB-Se concentrations and more rapid improve-
ment of foot lesions [12]. In this study, we found that
neutrophil function and the DTH and antibody titer
responses to a novel protein (KLH) were attenuated in
FR-affected sheep. The DTH and antibody titer responses
to a novel protein were improved, in part, by Se treat-
ment and WB-Se status, suggesting that FR in sheep is
associated with reduced lymphocyte function, which may
be partly restored by improving WB-Se status (≥ 250 ng/
mL). Additional experiments are needed to determine
the best source, route of administration, and dose of Se
to optimize immune function in sheep with FR.
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CFU: colony forming units; CMI: cell-mediated immunity; DTH: delayed-type
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